Guidelines recommend that all breast cancer patients be offered genetic testing, and a report indicates that disparities in cancer incidence and mortality between black and white Americans are getting smaller.

by Kate Yandell

A study finds that a new shingles vaccine is safe and likely effective in adult cancer patients, and a review article shows that some cancer patients with HIV can benefit from immunotherapy.

by Kate Yandell

Unsupported claims of a “complete cure” for cancer spread across the internet and airwaves, and a new policy aims to increase inclusion of older patients in research.

by Kate Yandell

A trial finds that it is safe to take a hormone-blocking drug to reduce prostate cancer risk, and direct-to-consumer genetic testing for cancer risk factors expands.

by Kate Yandell

A study sheds light on predicting immunotherapy response, and a company starts testing a digital chemotherapy pill.

by Kate Yandell

Government guidance asks hospitals to post prices online, and a study shows that cancer patients are less likely to enroll in clinical trials if they have coexisting health conditions.

by Kate Yandell

A financial transparency law goes into effect, researchers investigate a link between hot flashes and breast cancer, and the hunt for a better synthetic cell culture medium.

by Brad Jones

The Cancer Today editorial staff selects some of the most interesting and impactful reporting, research and perspectives of 2018.

by Cancer Today Staff

Judicial threats to the Affordable Care Act continue, and a study investigates the long-term risks of chemotherapy.

by Kate Yandell and Marci A. Landsmann

A long-term trial presents new evidence on who should have surgery for localized prostate cancer, and a review finds that women are temporarily at increased risk of breast cancer after giving birth.

by Kate Yandell